Author Correction: Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice

Documents similaires

• Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice.
  par: Nikisha Carty, et autres
  Publié: (2013)
• Cell therapy: a safe and efficacious therapeutic treatment for Alzheimer's disease in APP+PS1 mice.
  par: Neel R Nabar, et autres
  Publié: (2012)
• Epigenetic mechanisms underlying the effects of triptolide and tripchlorolide on the expression of neuroligin-1 in the hippocampus of APP/PS1 transgenic mice
  par: Xiaomei Lu, et autres
  Publié: (2019)
• The Hitchhiker’s Guide to Untargeted Lipidomics Analysis: Practical Guidelines
  par: Dmitrii Smirnov, et autres
  Publié: (2021)
• Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP/PS1 transgenic mice
  par: Long-Long Cao, et autres
  Publié: (2021)